Lurbinectedin (Pm01183) on Days (D) 1 & 8 in Combination with Capecitabine (Xel) in Patients (Pts) with Metastatic Breast (Mbc), Colorectal (Crc) or Pancreatic (Pac) Cancer | Publicación